Galderma Announces First Patient Enrollment in Study to Assess Nemolizumab in Adults With Chronic Pruritus of Unknown Origin
Business Wire India Chronic Pruritus of Unknown Origin (CPUO) is characterized by a persistent, chronic itch with an unknown…